Klingman & Associates LLC purchased a new stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 244 shares of the biopharmaceutical company’s stock, valued at approximately $201,000. Several other large investors have also recently […]
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the twenty-six brokerages that are covering the stock, Marketbeat reports. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and nineteen have assigned a buy rating to the company. […]
WP Advisors LLC reduced its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 0.7% during the third quarter, Holdings Channel reports. The fund owned 2,841 shares of the biopharmaceutical company’s stock after selling 20 shares during the period. Regeneron Pharmaceuticals comprises about 1.0% of WP Advisors LLC’s investment portfolio, making the […]
CENTRAL TRUST Co Sells 613 Shares of Regeneron Pharmaceuticals, Inc (NASDAQ:REGN) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Keel Point LLC bought a new stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 264 shares of the biopharmaceutical company’s stock, valued at approximately $217,000. Several other hedge funds also recently modified their holdings […]